pacira.com - PCRX Company profit before taxes, interest and amortization
The absolute EBITDA trend confirms that generic competition is pressuring Exparel revenue for Pacira BioSciences (PCRX). The decline in income is driven by a revision of hospital procurement and regulatory complexities regarding prescriptions. However, the scalability of non-opioid analgesics ensures high margins alongside low production costs. The current level of the 113.58 metric captures the operating cash flow dynamics, allowing for a real-time assessment of the business's actual profitability without reporting time lags.
Summary analytical data breakdowns for Pacira BioSciences, Inc. (PCRX)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Pacira BioSciences|PCRX - Long-Term Debt to Equity|Current Liabilities to Equity Pacira Pharmaceuticals|PCRX - Company Aggregate Debts|Debts to Book Capitalization Pacira BioSciences|PCRX - Company Long-Term Debts|Company Current Liabilities Pacira BioSciences|Interim Coverage Ratio pacira.com
- earnings and market ratios statistics:
PCRX - Company Net Income|Expected Net Income Pacira BioSciences|PCRX - P/E Multiple|Forward P/E Multiple pacira.com|PCRX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Pacira BioSciences|PCRX - Operating profit EBITDA|Earnings per share for the last twelve months Pacira BioSciences|PCRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months pacira.com|PCRX - Earnings per share growth in current year|Expected net earnings per share growth next year Pacira BioSciences
Summary company analytics:PCRX (Pacira Corp)
For Pacira BioSciences (PCRX), the actual cash flow from the sale of analgesic drugs determines the viability of the business. This metric captures the actual cash inflow from core operations, excluding the impact of depreciation, interest, and taxes. By analyzing the annual EBITDA, an investor can see the speed of fund receipts from insurance companies and clinics. Sharp fluctuations in the curve signal hidden liquidity problems. Ultimate stability depends on the ability of this flow to cover current liabilities.
Who Pacira BioSciences competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|ANIP (ANI Pharmaceuticals Inc) - Profit before deduction of interest, taxes, depreciation and amortization|MannKind Corp. - Operating profit EBITDA|AMPH - Operating profit EBITDA|SPRY: Operating profit EBITDA|Operating profit before deduction of amortization theravance.com|AQST (Aquestive Therapeutics, Inc.) - Operating profit EBITDA|scPharma (SCPH) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Tectonic Therapeutic, Inc. (TECX)|TNXP (Tonix Pharmaceuticals Holding) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Operating profit EBITDA Eupraxia Pharmaceuticals, Inc. EPRX|BHST: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization EXOZ (Invizyne Technologies)|ORMP: Operating profit EBITDA|ENTX (Entera Bio) - Profit before payment of interest, taxes and amortization|HYFT (MindWalk Holdings) - Operating profit EBITDA|abvcpharma.com (ABVC) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cumberland Pharmaceuticals Inc. (CPIX)|QNTM - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization FibroGen Corp FGEN|Operating income before deduction of amortization Telomir Pharmaceuticals Corp (TELO)|Rani Therapeutics Inc - Operating profit EBITDA|Synergy CHC Corp (SNYR) - Operating profit before deduction of amortization|RLYB: Operating profit EBITDA|LEXX - Operating income before deduction of amortization|PULM (Pulmatrix Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization Pheton PTHL|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|lyratherapeutics.com - Operating profit before amortization|Operating profit EBITDA IBO (Impact BioMedical)|TNFA - Operating profit before deduction of amortization|cbdMD Corp - Operating profit EBITDA|Profit before interest, taxes and amortization PainReform Corp|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|LIPO - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PROC|Operating profit before deduction of amortization Petros Pharma PTPI|Profit before payment of interest, taxes and amortization Qilian International QLI|Income before deduction of interest, taxes and amortization SLRN|TFFP: Operating profit before deduction of amortization
